Pathogenesis of Graves’ orbitopathy: A 2010 update

B Cells from Patients with Graves' Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis

(2014) R. S. Douglas et al.   JOURNAL OF IMMUNOLOGY

Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease

(2014) S. Tsui et al.   JOURNAL OF IMMUNOLOGY

Rituximab for the Treatment of Non-Hodgkinʼs Lymphoma and Chronic Lymphocytic Leukaemia

(2010) Fredrick Hagemeister   DRUGS

Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves’ Orbitopathy: A Retrospective Cohort Study

(2010) Adriana Lai et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Graves' Ophthalmopathy

(2010) Rebecca S. Bahn   NEW ENGLAND JOURNAL OF MEDICINE

Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?

(2010) T. J. Smith   PHARMACOLOGICAL REVIEWS

Evidence of orbital B and T cell depletion after rituximab therapy in Graves’ ophthalmopathy

(2009) Jacob F. Nielsen et al.   ACTA OPHTHALMOLOGICA

Development of Criteria for Evaluating Clinical Response in Thyroid Eye Disease Using a Modified Delphi Technique

(2009) Raymond S. Douglas   ARCHIVES OF OPHTHALMOLOGY

Failure of rituximab treatment in a case of severe thyroid ophthalmopathy unresponsive to steroids

(2009) Gerasimos E. Krassas et al.   CLINICAL ENDOCRINOLOGY

Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts

(2009) Lei Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Divergent Frequencies of IGF-I Receptor-Expressing Blood Lymphocytes in Monozygotic Twin Pairs Discordant for Graves’ Disease: Evidence for a Phenotypic Signature Ascribable to Nongenetic Factors

(2009) Raymond S. Douglas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Graves’ Orbitopathy Activation after Radioactive Iodine Therapy with and without Steroid Prophylaxis

(2009) G. Vannucchi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment Modalities for Graves’ Ophthalmopathy: Systematic Review and Metaanalysis

(2009) Hadas Stiebel-Kalish et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131

(2009) Frank Träisk et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Role of 11ß-Hydroxysteroid Dehydrogenase 1 in Adipogenesis in Thyroid-Associated Ophthalmopathy

(2009) Jeremy W. Tomlinson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy

(2009) Raymond S. Douglas et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

TSH Receptor and Thyroid-Specific Gene Expression in Human Skin

(2009) Francesca Cianfarani et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

B-cell-directed therapies for autoimmune disease

(2009) Thomas Dörner et al.   Nature Reviews Rheumatology

Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy

(2009) Dinesh Khanna et al.   OPHTHALMOLOGY

Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies

(2008) Daniel El Fassi et al.   CLINICAL IMMUNOLOGY

Rituximab in relapsing Graves' disease, a phase II study

(2008) Karen A Heemstra et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY